New York Times Feed

HEALTHCARE

JFDA withdraws Zantac from pharmacies over carcinogen fearsOctober 20, 2019

AMMAN — Zantac, a medicine used as an anti-acid and to treat ulcers, has recently been withdrawn from pharmacies, according to the Jordan Food and Drug Administration (JFDA).

The JFDA withdrew the drug, prescribed in tablet form and as an injection, in response to a circulation by global health institutions about small quantities of the contaminant N-Nitrosodimethylamine (NDMA), detected in the medicine, according to a JFDA statement made"...

Continue Reading >
New Research Reveals Updated Patient Preferences on Digital Health TechnologyOctober 19, 2019

ResMed (NYSE: RMD, ASX: RMD) today announced results from a company-led survey, revealing new patient preferences on digital health technology. The survey highlights a reason for optimism that the markets for digital health technology will only continue to grow.

The survey of a nationally representative sample of 3,000 Americans, conducted in partnership with Edelman Intelligence, revealed that the use of – and confidence in – remote"...

Continue Reading >
Concept Medical is Granted CE Certification for Their Sirolimus Coated MagicTouch Group of ProductsOctober 18, 2019

Concept Medical B.V. with its headquarters in Tampa, Florida has announced that on 16th October 2019, they have received the CE certification for their MagicTouch group of products. The CE certified products/brands are as listed below: MagicTouch – PTA (Sirolimus Coated PTA Balloon Catheter) for peripheral arterial disease MagicTouch – ED (Sirolimus Coated Balloon Catheter) for Erectile Dysfunction MagicTouch – AVF (Sirolimus Coated PTA Balloon Catheter) for Arterio-Venous Fistula and Graft MagicTouch – PTA is the only commercially available and CE certified Sirolimus coated balloon catheter for peripheral arterial diseases. Percutaneous transluminal angioplasty (PTA) is a procedure that can open a blocked blood vessel using a small catheter with a balloon at one end. The currently accepted procedure is to use drug delivery devices to deliver drugs that inhibit......

Continue Reading >
186 healthcare professionals land jobs in Qatar — Labour Ministry -October 17, 2019

AMMAN — The Ministry of Labour on Wednesday announced the signing of 186 contracts for Jordanian healthcare professionals in Qatar.

In a statement carried by the Jordan News Agency, Petra, the ministry said that 35 jobseekers have also been recruited to work as car electricians in the UAE.

Labour Ministry Spokesperson Mohammed Khatib said the ministry announced last"...

Continue Reading >
Johns Hopkins Center for Health Security, World Economic Forum and Bill & Melinda Gates Foundation Host Pandemic Exercise and Livestream October 17, 2019

The Johns Hopkins Center for Health Security, with the World Economic Forum and the Bill & Melinda Gates Foundation, will host Event 201, a multimedia global pandemic exercise on Friday, Oct. 18, 2019, in New York City. The public may register and participate in the simultaneous virtual exercise in English, 8:50 a.m.-12:30 p.m. EDT at centerforhealthsecurity.org/event201/. The exercise underscores the need for global public-private cooperation to mitigate economic and societal impacts of severe pandemics. In recent years, the world has seen a growing number of epidemic events, about 200 per year, which strain limited resources. A large global pandemic would be disruptive to health, economies, and society. Economic studies show that pandemics could be the cause of an average annual economic loss of 0.7% of global GDP—or $570 billion. Event 201, played by 15 leaders of businesses,......

Continue Reading >
Boehringer Ingelheim Announces First Patient Enrolled in Phase II Trial of Novel Cystic Fibrosis Treatment (BALANCE-CFTM 1)October 16, 2019

Boehringer Ingelheim today announced the first patient enrolled in its Phase II clinical trial BALANCE-CFTM 1 to evaluate a new potential treatment for cystic fibrosis.1,2 The trial will investigate how different doses of the compound, an inhaled epithelial sodium channel (ENaC) inhibitor, impact lung function compared to placebo when added to the standard of care in adults and adolescents with cystic fibrosis.1,3,4

People with cystic fibrosis have"...

Continue Reading >
Accomplishments of Dr. Steven Rosenberg in Cancer Immunotherapy Inspire Young Researchers in Japan & XIV Fujio Cup Quiz on Stem Cells Is Won by India.October 16, 2019

Utilizing the capability of one’s own immune system to tackle cancer, an out-of-the box idea was the brain child of Dr. Steven Rosenberg almost three decades ago. His initiative which paved way for a new chapter in oncology, inspired many young scientists and clinicians in the NCRM NICHE 2019 held in Tokyo, Japan, as his acceptance speech in the Edogawa NICHE Prize ceremony was videocast.

NCRM NICHE, an active knowledge gaining academic event"...

Continue Reading >
Czech Republic, Jordan see medical tourism as promising channel for cooperationOctober 15, 2019

AMMAN — The ambassador of the Czech Republic to Jordan, Josef Koutský, on Monday highlighted the strong Amman-Prague relations, shedding light on his country’s contributions to the health sector.

“Every year, several medical teams of different specialisations carry out hundreds of operations in Jordanian hospitals. More than 3,700 patients were operated on by Czech doctors from 2013 till now in Amman,” a Czech embassy"...

Continue Reading >
Takeda Agrees to Divest Select OTC and Non-core Assets to Acino for Over $200 Million USDOctober 15, 2019

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select over-the-counter (OTC) and prescription pharmaceutical assets in a number of Near East, Middle East and Africa (NEMEA) countries within its Growth and Emerging Markets Business Unit to Acino for a total value in excess of $200 million USD. This is the third transaction in FY19 that furthers Takeda’s strategy to focus on business areas core to its long-term"...

Continue Reading >
International Healthcare Travel Forum to kick off on October 26October 14, 2019

AMMAN — The Kingdom has witnessed a 25 per cent drop in the rate of medical tourists since 2016, according to the Private Hospitals Association (PHA).

During a press conference held on Saturday to announce the 'International Healthcare Travel Forum' (IHTF2019) in Amman from October 26-28, PHA President Fawzi Hammouri attributed the decrease to former prime minister Abdullah Ensour's government’s decision to suspend and restrict"...

Continue Reading >